| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 18 | |
| #2 | EPO (European Patent Office) | 16 | |
| #3 | Israel | 14 | |
| #4 | Australia | 13 | |
| #5 | Hong Kong | 13 | |
| #6 | China | 11 | |
| #7 | Taiwan | 11 | |
| #8 | WIPO (World Intellectual Property Organization) | 11 | |
| #9 | Argentina | 10 | |
| #10 | Canada | 10 | |
| #11 | New Zealand | 10 | |
| #12 | Mexico | 9 | |
| #13 | Singapore | 9 | |
| #14 | Republic of Korea | 8 | |
| #15 | Peru | 6 | |
| #16 | Ukraine | 4 | |
| #17 | Brazil | 3 | |
| #18 | Chile | 3 | |
| #19 | Colombia | 3 | |
| #20 | Costa Rica | 3 | |
| #21 | Ecuador | 3 | |
| #22 | Hungary | 3 | |
| #23 | Malaysia | 3 | |
| #24 | Nicaragua | 3 | |
| #25 | Philippines | 3 | |
| #26 | Dominican Republic | 1 | |
| #27 | EAPO (Eurasian Patent Organization) | 1 | |
| #28 | Japan | 1 | |
| #29 | Norway | 1 | |
| #30 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Foods and drinks | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Special acyclic compounds | |
| #6 | Organic chemistry methods | |
| #7 | Microorganisms | |
| #8 | Enzymes | |
| #9 | Analysing materials | |
| #10 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Ly Tai Wei | 141 |
| #2 | Potter Garrett Thomas | 71 |
| #3 | Raaum Erik Dean | 39 |
| #4 | Forrester Jared Andrew | 29 |
| #5 | Bacon Kevin | 22 |
| #6 | Li Yingfu | 17 |
| #7 | Fukushima Keiko | 17 |
| #8 | Urbahns Klaus | 16 |
| #9 | Nunami Noriko | 16 |
| #10 | Moriwaki Toshiya | 16 |
| Publication | Filing date | Title |
|---|---|---|
| AR103264A1 | DERIVATIVES OF 3,5-AMINOPIRAZOL AS INHIBITORS OF QUINASA RC | |
| NZ631142A | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors | |
| AU2013312420A1 | Isotopically enriched arylsulfonamide CCR3 antagonists | |
| TW201341367A | 3,5-diaminopyrazole kinase inhibitors | |
| AU2012238285A1 | Benzenesulfonamide derivatives | |
| MX2013003954A | Salts of arylsulfonamide ccr3 antagonists. | |
| MX2012010714A | Arylsulfonamide ccr3 antagonists. | |
| WO2011109345A1 | Isotopically enriched arylsulfonamide ccr3 antagonists | |
| TW201041583A | 2,5-disubstituted arylsulfonamide CCR3 antagonists | |
| KR20160064240A | 2,5-disubstituted arylsulfonamide ccr3 antagonists | |
| TW201040150A | Arylsulfonamide ccr3 antagonists | |
| AU2004251181A1 | Regulation of kinase, 'regulated in COPD kinase' (RC kinase) | |
| EP1608374A1 | 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |